Advertisement
In a letter to Gowda, he said that it has been noticed that pharmaceutical companies have raised the prices of Amphotercin, a drug used in the management of this infection and shortage of this medicine has also been reported.
“I would request your urgent intervention in this matter to regulate the prices and supply of the medicine for this deadly Mucormycosis infection to ensure that no artificial shortage is created,” Prabhu said.
He added that there has been an increase in the cases of this disease.
Related Articles
Advertisement